129 related articles for article (PubMed ID: 10593303)
1. Preliminary observations on APOE epsilon4 allele and progression of disability in multiple sclerosis.
Chapman J; Sylantiev C; Nisipeanu P; Korczyn AD
Arch Neurol; 1999 Dec; 56(12):1484-7. PubMed ID: 10593303
[TBL] [Abstract][Full Text] [Related]
2. Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis.
De Stefano N; Bartolozzi ML; Nacmias B; Zipoli V; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; Amato MP
Arch Neurol; 2004 Apr; 61(4):536-40. PubMed ID: 15096402
[TBL] [Abstract][Full Text] [Related]
3. No association of apolipoprotein E epsilon4 genotype with faster progression or less recovery of relapses in a Spanish cohort of multiple sclerosis.
Sedano MI; Calmarza P; Perez L; Trejo JM
Mult Scler; 2006 Feb; 12(1):13-8. PubMed ID: 16459715
[TBL] [Abstract][Full Text] [Related]
4. Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele.
Enzinger C; Ropele S; Strasser-Fuchs S; Kapeller P; Schmidt H; Poltrum B; Schmidt R; Hartung HP; Fazekas F
Arch Neurol; 2003 Jan; 60(1):65-70. PubMed ID: 12533090
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score.
Guerrero AL; Laherrán E; Gutiérrez F; Martín-Polo J; Iglesias F; Alcázar C; Peralta J; Rostami P
Acta Neurol Scand; 2008 Jan; 117(1):21-5. PubMed ID: 17883422
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy.
van der Walt A; Stankovich J; Bahlo M; Taylor BV; van der Mei IA; Foote SJ; Kilpatrick TJ; Rubio JP; Butzkueven H
Neurology; 2009 Sep; 73(13):1018-25. PubMed ID: 19786693
[TBL] [Abstract][Full Text] [Related]
7. Association of apolipoprotein E genotypes with prognosis in multiple sclerosis.
Tamam Y; Tasdemir N; Yalman M; Tamam B
Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1122-30. PubMed ID: 22165672
[TBL] [Abstract][Full Text] [Related]
8. Apo E in multiple sclerosis and optic neuritis: the apo E-epsilon4 allele is associated with progression of multiple sclerosis.
Pinholt M; Frederiksen JL; Andersen PS; Christiansen M
Mult Scler; 2005 Oct; 11(5):511-5. PubMed ID: 16193886
[TBL] [Abstract][Full Text] [Related]
9. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP
Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
[TBL] [Abstract][Full Text] [Related]
10. APOE genotype is a major predictor of long-term progression of disability in MS.
Chapman J; Vinokurov S; Achiron A; Karussis DM; Mitosek-Szewczyk K; Birnbaum M; Michaelson DM; Korczyn AD
Neurology; 2001 Feb; 56(3):312-6. PubMed ID: 11171894
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of apolipoprotein E and Japanese patients with multiple sclerosis.
Niino M; Kikuchi S; Fukazawa T; Yabe I; Tashiro K
Mult Scler; 2003 Aug; 9(4):382-6. PubMed ID: 12926843
[TBL] [Abstract][Full Text] [Related]
12. Association of APOE epsilon4 allele with survival in amyotrophic lateral sclerosis.
Drory VE; Birnbaum M; Korczyn AD; Chapman J
J Neurol Sci; 2001 Sep; 190(1-2):17-20. PubMed ID: 11574101
[TBL] [Abstract][Full Text] [Related]
13. Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate.
Høgh P; Oturai A; Schreiber K; Blinkenberg M; Jørgensen OS; Ryder L; Paulson OB; Sørensen PS; Knudsen GM
Mult Scler; 2000 Aug; 6(4):226-30. PubMed ID: 10962542
[TBL] [Abstract][Full Text] [Related]
14. APOE genotypes and disease severity in multiple sclerosis.
Masterman T; Zhang Z; Hellgren D; Salter H; Anvret M; Lilius L; Lannfelt L; Hillert J
Mult Scler; 2002 Apr; 8(2):98-103. PubMed ID: 11990879
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E ε4-positive multiple sclerosis patients develop more gray-matter and whole-brain atrophy: a 15-year disease history model based on a 4-year longitudinal study.
Horáková D; Kýr M; Havrdová E; Doležal O; Lelková P; Pospíšilová L; Bergsland N; Dwyer MG; Cox JL; Hussein S; Seidl Z; Vaněčková M; Krásenský J; Zivadinov R
Folia Biol (Praha); 2010; 56(6):242-51. PubMed ID: 21324265
[TBL] [Abstract][Full Text] [Related]
16. Association of the APOE epsilon4 allele with disease activity in multiple sclerosis.
Evangelou N; Jackson M; Beeson D; Palace J
J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):203-5. PubMed ID: 10406990
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E genotype does not influence the progression of multiple sclerosis.
Savettieri G; Andreoli V; Bonavita S; Cittadella R; Caltagirone C; Fazio MC; Girlanda P; Le Pira F; Liguori M; Logroscino G; Lugaresi A; Nocentini U; Reggio A; Salemi G; Serra P; Tedeschi G; Toma L; Trojano M; Valentino P; Quattrone A
J Neurol; 2003 Sep; 250(9):1094-8. PubMed ID: 14504972
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis.
Fazekas F; Strasser-Fuchs S; Kollegger H; Berger T; Kristoferitsch W; Schmidt H; Enzinger C; Schiefermeier M; Schwarz C; Kornek B; Reindl M; Huber K; Grass R; Wimmer G; Vass K; Pfeiffer KH; Hartung HP; Schmidt R
Neurology; 2001 Sep; 57(5):853-7. PubMed ID: 11552016
[TBL] [Abstract][Full Text] [Related]
19. [Apolipoprotein E polymorphism as a predictor of progression of multiple sclerosis].
Guerrero AL; Bueno V; Hernández MT; Martín-Serradilla JI; Carrasco E; Cuadrado I
Neurologia; 2003 Apr; 18(3):146-8. PubMed ID: 12677480
[TBL] [Abstract][Full Text] [Related]
20. No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis.
Zwemmer JN; van Veen T; van Winsen L; van Kamp GJ; Barkhof F; Polman CH; Uitdehaag BM
Mult Scler; 2004 Jun; 10(3):272-7. PubMed ID: 15222690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
